3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
25
Neoplasms
3
Neoplasm Metastasis
3
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
2
Urogenital Neoplasms
1
Prostatic Diseases
1
Prostate Cancer Metastatic
1
Neoplasms, Glandular and Epithelial
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castrate-resistant Prostate Cancer
1
Hormone-Refractory Prostate Cancer
1
Genital Neoplasms, Male
1
Carcinoma
1
Adenocarcinoma of the Prostate
1
Adenocarcinoma
1
Interventions
enzalutamide
2
sipuleucel-T
1
pazopanib
1
capivasertib
1
Watchful Waiting
1
STA 9090
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiosurgery
1
Dutasteride
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Adenocarcinoma of the Prostate
×
sipuleucel-T
×
Clear all
NCT03686683
2024-10-08
ProVent
Dendreon
Phase 3
Completed
532 enrolled
14 charts